Tolerability of CAR-T therapies in clinical trials and in the real-world

(2:)

DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dex in RRMM

(5:38)

VISION: tolerability of 177Lu-PSMA-617 by treatment exposure in patients with mCRPC

(3:3)

Dr. Sharma on Tolerability of SIRT in Patients With CRC

(1:11)

Safety and tolerability of AdAPT-001 in Phase II trial: no dose-limiting toxicity observed

(46)

Tolerability of monoclonal antibodies in multiple myeloma

(1:13)

Safety and tolerability of nintedanib in patients with interstitial lung disease

(4:39)

Dr. Shore on the Tolerability of Darolutamide in Nonmetastatic CRPC

(2:)

Safety and Tolerability of Very Low LDL Levels in Patients Treated with 52 Weeks of Evolocumab

(5:13)

Tolerability of ribociclin in elderly patients

(1:25)

Safety and tolerability of the vepdegestrant in breast cancer

(2:1econd)

Safety, efficacy and tolerability of ide-cel in the real-world

(2:8)

Tolerability of current treatments for dry eye disease – Video abstract [465143]

(1:50)

Tolerability of Multiple Myeloma Therapy

(20:31)

Tolerability of Triplet Therapy in Multiple Myeloma

(4:31)

Tolerability of Dolutegravir and the other INSTI’s

(19:12)

Understanding Treatment Tolerability in Older Patients with Advanced Cancer

(59:48)

Safety and tolerability of AVB500 in platinum-resistant recurrent ovarian cancer

(4:23)

Christopher Granger, MD: Patient Tolerability of Anticoagulants

(3:16)

Efficacy \u0026 tolerability of anti-thrombotic therapy in patients with HHT

(1:50)